ARF-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (ARAP1) is a protein that in humans is encoded by the ARAP1 gene. It's a multi-domain protein that is known to interact with various signaling molecules, making it a key player in intracellular communication and coordination.ARAP1 has several functional domains including ARF-GAP, Rho-GAP, Ankyrin repeat, and Pleckstrin homology (PH) domains. The ARF-GAP and Rho-GAP domains provide ARAP1 the ability to act as a GTPase-activating protein for both ARF and Rho family GTPases, which are key regulators of many cellular processes including cell shape and movement, vesicle trafficking, and gene expression.
The Ankyrin repeat domain allows ARAP1 to interact with other proteins, while the PH domain enables it to bind to phosphoinositides, a type of phospholipid found in the cell membrane. These interactions likely help target ARAP1 to specific cellular locations and mediate its effects on cell signaling.It has been implicated in various diseases, including cancer. For example, changes in ARAP1 expression or function disrupt normal cell behavior and contribute to the uncontrolled growth or migration of cancer cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, potentially affecting Rho signaling pathways in which ARAP1 may be involved. | ||||||
SU 6668 | 252916-29-3 | sc-204309 sc-204309A | 10 mg 50 mg | $127.00 $712.00 | 2 | |
ML141 is a Cdc42 inhibitor, which could influence ARAP1's role in modulating Rho GTPase signaling. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Arf-mediated vesicular trafficking, potentially affecting ARAP1-regulated pathways. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA activates Rho GTPase signaling and might indirectly influence ARAP1 activity. | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | $30.00 $90.00 | 8 | |
CCG-1423 inhibits Rho-mediated transcription, which could impact signaling pathways involving ARAP1. | ||||||
3-[6-(Dimethylamino)-4-methyl-3-pyridinyl]-2,5-dimethyl-N,N-dipropylpyrazolo[1,5-a]pyrimidin-7-amine | 195055-03-9 | sc-498264 | 10 mg | $380.00 | ||
Rhosin specifically inhibits RhoA activation, potentially affecting ARAP1-mediated signaling pathways. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
ZCL278 is a Cdc42 inhibitor, potentially influencing ARAP1's function in cytoskeletal organization and signaling. | ||||||